@article{article9a9ada4e,
title   = {First-line trastuzumab plus an aromatase inhibitor, with or without pertuzumab, in human epidermal growth factor Receptor 2-positive and hormone receptor-positive metastatic or locally advanced breast cancer (PERTAIN): a randomized, open-label phase II trial},
author = {Rimawi, Mothaffar and Ferrero, Jean-Marc and Haba-rodriguez, Juan de la and Poole, Christopher and Placido, Sabino De and Osborne, C. Kent and Hegg, Roberto and Easton, Valerie and Wohlfarth, Christine and Arpino, Grazia},
year = {2018},
doi = {10.1200/JCO.2017.76.7863},
journal   = {Journal of clinical oncology}
}